Regal Investment Advisors’s GSK GSK Stock Holding History

Regal Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-800	Closed	-$38K	–	546
2021 Q3	$38K	Hold	800	–	–	﹤0.01%	524
2021 Q2	$40K	Buy	+800	New	+$38.4K	﹤0.01%	527
2021 Q1	–	Sell	-800	Closed	-$37K	–	196
2020 Q4	$37K	Buy	+800	New	+$36.7K	﹤0.01%	465
2020 Q3	–	Sell	-800	Closed	-$41K	–	101
2020 Q2	$41K	Buy	+800	New	+$41K	0.01%	328

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Regal Investment Advisors's GSK Position: Q1 2026 in Review

Regal Investment Advisors increased its GSK (GSK) stake by 13% in Q1 2026, buying an estimated $51K and bringing the position to 8,222 shares worth $454K. The position accounts for 0.03% of the portfolio, ranked #453.

Regal Investment Advisors first reported a position in GSK in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.02M in Q1 2024. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Regal Investment Advisors held 8,222 shares of GSK worth $454K as of Q1 2026.
Regal Investment Advisors bought 942 GSK shares in Q1 2026, an estimated $51K.
GSK made up 0.03% of Regal Investment Advisors's portfolio in Q1 2026, its #453 holding.
Regal Investment Advisors first reported a position in GSK in Q2 2013 and has held it in 39 quarters since.
Regal Investment Advisors's GSK position peaked at $1.02M in Q1 2024.
1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Regal Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.